Eli Lilly & Co., headquartered in Indianapolis, employs 43,000 staff and develops various pharmaceutical products, including diabetes, oncology, immunology, and neuroscience therapies, alongside radiopharmaceuticals through its subsidiary POINT Biopharma. The company manufactures and distributes products in the U.S., Europe, and Asia.
LLY has been in the news recently: WW International Inc shares surged by 110% after partnering with Eli Lilly's Gifthealth to enhance access to the weight loss drug Zepbound. This collaboration highlights Eli Lilly's involvement in expanding the availability of its weight loss treatments.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.